Home Cart 0 Sign in  
X

[ CAS No. 116313-85-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 116313-85-0
Chemical Structure| 116313-85-0
Chemical Structure| 116313-85-0
Structure of 116313-85-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 116313-85-0 ]

Related Doc. of [ 116313-85-0 ]

Alternatived Products of [ 116313-85-0 ]

Product Details of [ 116313-85-0 ]

CAS No. :116313-85-0 MDL No. :MFCD00871897
Formula : C7H5NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :BBFJODMCHICIAA-UHFFFAOYSA-N
M.W : 183.12 Pubchem ID :5748957
Synonyms :

Calculated chemistry of [ 116313-85-0 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 44.7
TPSA : 103.35 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.67 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.02
Log Po/w (XLOGP3) : 1.05
Log Po/w (WLOGP) : 0.82
Log Po/w (MLOGP) : -0.85
Log Po/w (SILICOS-IT) : -1.09
Consensus Log Po/w : -0.01

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.85
Solubility : 2.61 mg/ml ; 0.0142 mol/l
Class : Very soluble
Log S (Ali) : -2.81
Solubility : 0.283 mg/ml ; 0.00154 mol/l
Class : Soluble
Log S (SILICOS-IT) : -0.58
Solubility : 48.5 mg/ml ; 0.265 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 1.0 alert
Brenk : 4.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.91

Safety of [ 116313-85-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 116313-85-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 116313-85-0 ]
  • Downstream synthetic route of [ 116313-85-0 ]

[ 116313-85-0 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 6635-20-7 ]
  • [ 116313-85-0 ]
YieldReaction ConditionsOperation in experiment
86% With pyridine; aluminum (III) chloride In chloroform at 0℃; for 16 h; Reflux Compound 104 (10 g, 50.76 mmol) was added to a stirred suspension of AICI3 (7.44 g, 55.83 mmol) in dry chloroform (150 mL) at 0°C. Pyridine (18.0 mL, 223.35 mmol) was dropwise added to the resulting mixture, and the mixture was refluxed for 16h. The mixture was cooled to room temperature and poured into ice water. The solid was filtered, and the residue was purified by silica gel column chromatography to give the title compound 105 (8.0 g, 86percent) . 1HNMR (400 MHz, DMSO-d6) : δ 10.91 (br s, 2H) , 9.81 (s, 1H) , 7.98 (d, J= 2.0 Hz, 1H) , 7.46 (d, J = 2.0Hz, 1H) .
73% With 1-N-ferrocenylmethyl benzimidazole tagged polymer In N,N-dimethyl-formamideReflux General procedure: A mixture of aryl methyl ether (1 mmol) and [FemMerBenz]Al2Cl7 (200 mg, 0.96 mol percent) in DMF (5 mL) was refluxed in an oil bath. After completion of the reaction as monitored by the TLC, the reaction mixture was cooled and filtered. The filtrate was poured into water (20 mL) and extracted with ethyl acetate (3 20 mL). The combined organic layers were dried over Na2SO4. Evaporation of the solvent followed by column chromatography over silica gel using ethyl acetate/ petroleum ether (1:4 v/v) afforded pure O-demethylated product, which was characterized by spectral methods.
71% With pyridine; aluminium(III) iodide In acetonitrile at 80℃; for 18 h; General procedure: To a solution of AlI3 (36.6 mmol, 1.1 equiv) in MeCN (100 mL)was added dropwise a solution of pyridine (12.2 g, 154.2 mmol,4.6 equiv) and eugenol (5.4 g, 33.0 mmol). The mixture wasstirred at 80 °C for 18 h. After cooling to room temperature, themixture was quenched with aq HCl (2 mol/L, 50 mL), and wasextracted with EtOAc (4 × 50 mL). The combined organic phaseswere washed with brine and dried by MgSO4. After evaporationof solvents by a rotary evaporator, the residue was purifiedthrough flash column chromatography to afford 5 as a whitesolid (4.9 g, 99percent).
71%
Stage #1: With pyridine; iodine; aluminium In acetonitrile for 18 h; Reflux
Stage #2: With hydrogenchloride In water; acetonitrile at 20℃;
To a 100 ml eggplant flask were added iodine (2.095 g), aluminum powder (0.368 g) and acetonitrile (40 ml), heated toReflux, stir for 2 hours to the purple red of iodine disappears. Pyridine (1.597 g) and 5-nitro vanillin (0.986 g) were added and the reaction was continuedThe reaction was carried out for 18 hours. After stirring, the mixture was cooled to room temperature and then 2 mol / L dilute hydrochloric acid (10 ml) was added to the reaction solution,Ester (50 ml x 3). The organic phases were combined and dried over anhydrous sodium sulfate. The filtrate was evaporated to dryness with a rotary evaporator and the residue was removedPurification by flash column chromatography (mobile phase ethyl acetate: petroleum ether = 1: 3, volume ratio) gave 3,4-dihydroxy-5-nitroBenzaldehyde (yellow solid, 0.650 g, 71percent yield).
50% With hydrogen bromide In water for 4 h; Reflux A solution of 94 (3.5 g, 17.8 mmol) in hydrobromic acid (48percent, 32 ml) was refluxed for 4 h. After cooling to room temperature and addition of water and ice, the precipitate was filtered off and washed with cold water, to give compound 95 as a brown solid (1.62 g, 50percent). 1H NMR (300 MHz, DMSO-d6): δ = 7.46 (d, J = 1.9 Hz, 1H), 7.95 (d, J = 1.9 Hz, 1H), 9.79 (s, 1H), 10.52 (br m, 2H) ppm; 13C NMR (75 MHz, DMSO-d6): δ = 115.8, 119.6, 127.0, 137.2, 147.2, 148.3, 190.5 ppm; HRMS (ESI): m/z [M-H]- calcd for C7H4NO5: 182.0059, found: 182.0088.
43% With aluminium(III) iodide; diisopropyl-carbodiimide In acetonitrile at 80℃; for 18 h; General procedure: To a suspension of AlI3 (5.5 mmol, 1.1 equiv) in hot CH3CN (40 mL) were added sequentially DIC (0.379 g, 3 mmol, 0.6 equiv) and eugenol (1, 0.821 g, 5.0 mmol). The mixture was stirred for 18 h at 80 °C, and then it was cooled to r.t., acidified with HCl (2 mol/L, 10 mL), and extracted with EtOAc (3 × 50 mL). The organic phases were combined, washed with sat. aq Na2S2O3 (10 mL) and brine (10 mL), and was dried (MgSO4). The solvent was removed on a rotary evaporator and the residue was purified by flash column chromatography (PE/EtOAc, 4:1) to afford 2 (0.750 g, 99percent) as a white solid
43% With aluminium(III) iodide; diisopropyl-carbodiimide In acetonitrile at 80℃; for 18 h; To a 100 ml eggplant flask were added aluminum triiodide (2.248 g), acetonitrile (40 ml) Heated to reflux, followed by the addition of DIC (0.378 g) and 5-nitro vanillin (0.986 g), heated to 80 ° C, After stirring for 18 hours, the mixture was stirred, cooled to room temperature and then acidified with 2 mol / L dilute hydrochloric acid (10 ml) And extracted with ethyl acetate (50 ml X). The combined organic phases were washed first with a saturated aqueous solution of sodium thiosulfate (10 ml), washed with saturated brine (10 ml), dried over anhydrous magnesium sulfate, filtered and the filtrate was evaporated Instrument evaporated, The residue was purified by flash column chromatography (eluent: ethyl acetate / petroleum ether = 2: 3, volume ratio) To give 0.395 g of 3,4-dihydroxy-5-nitrobenzaldehyde (yellow solid in 43percent yield)
39.5% at 90℃; for 17 h; 00455] Intermediate 45 : Synthesis of 8-nitro-2,3-dihydrobenzo[b][l,4]dioxine-6- carbaldehyde:[00456] Step 1: Synthesis of 3,4-dihydroxy-5-nitrobenzaldehyde: To a solution of 4-hydroxy-3-methoxy-5-nitrobenzaldehyde (3 g, 15.2 mmol) in acetic acid (3.1 mL) was added 40percent hydrobromic acid (9.24 mL). The mixture was heated at 90°C for 17 h. Reaction mixture was cooled and poured into ice water (100 mL), followed by a standardaqueous/EtOAc workup and purified by column chromatography on silica gel (petroleum ether/ethyl acetate =5: 1) to give 3,4-dihydroxy-5-nitrobenzaldehyde (1.1 g, yield 39.5percent).
14% With aluminium(III) iodide; calcium oxide In acetonitrile at 80℃; for 18 h; To a 100 ml eggplant flask was added aluminum triiodide (2.242 g, 5.5 mmol), acetonitrile (40 ml),CaO (0.421 g, 7.5 mmol) and 5-nitro vanillin (0.985 g, 5.0 mmol) were heated to 80 °C,After 18 hours of reaction, stirring was stopped. After cooling to room temperature, 2 mol/L dilute hydrochloric acid (10 ml) was acidified in an eggplant-shaped flask.Extract with ethyl acetate (50ml x 3) and combine the organic phases and wash first with saturated aqueous sodium thiosulfate (10ml).It was washed with saturated brine (10 ml), dried over anhydrous magnesium sulfate, filtered, and the filtrate was evaporated to dryness on a rotary evaporator.The residue was purified by flash column chromatography (eluent: ethyl acetate/petroleum ether=1:3, volume ratio).0.131 g of 3,4-dihydroxy-5-nitrobenzaldehyde (yellow solid, yield 14percent) was obtained.

Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 5, p. 1969 - 1989
[2] Journal of Organic Chemistry, 2000, vol. 65, # 23, p. 8001 - 8010
[3] Journal of the American Chemical Society, 2000, vol. 122, # 44, p. 10781 - 10787
[4] Organic Letters, 2008, vol. 10, # 7, p. 1369 - 1372
[5] Patent: WO2016/199943, 2016, A1, . Location in patent: Paragraph 0402
[6] Synthetic Communications, 2002, vol. 32, # 4, p. 641 - 649
[7] Tetrahedron Letters, 2012, vol. 53, # 47, p. 6361 - 6366,6
[8] Synlett, 2017, vol. 28, # 1, p. 138 - 142
[9] Patent: CN106278825, 2017, A, . Location in patent: Paragraph 0080; 0081; 0082; 0083
[10] Journal of Medicinal Chemistry, 1992, vol. 35, # 24, p. 4584 - 4588
[11] Journal of Medicinal Chemistry, 2010, vol. 53, # 8, p. 3396 - 3411
[12] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 24, p. 7318 - 7337
[13] Synthesis (Germany), 2017, vol. 49, # 12, p. 2721 - 2726
[14] Patent: CN106866377, 2017, A, . Location in patent: Paragraph 0179-0181
[15] Patent: WO2011/38204, 2011, A1, . Location in patent: Page/Page column 149
[16] Patent: CN107473916, 2017, A, . Location in patent: Paragraph 0105-0107
[17] Chemische Berichte, 1903, vol. 36, p. 2935
[18] Patent: WO2005/63695, 2005, A1, . Location in patent: Page/Page column 10
[19] Patent: US5236952, 1993, A,
[20] Synthetic Communications, 2008, vol. 38, # 15, p. 2507 - 2520
[21] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 24, p. 6553 - 6557
[22] Patent: US2010/234632, 2010, A1, . Location in patent: Page/Page column 3-4
[23] Patent: WO2015/69110, 2015, A1, . Location in patent: Page/Page column 70; 71
  • 2
  • [ 6635-20-7 ]
  • [ 7440-44-0 ]
  • [ 116313-85-0 ]
YieldReaction ConditionsOperation in experiment
80% With acetic acid In conc. hydrobromic acid; water EXAMPLE 111
3,4-Dihydroxy-5-nitrobenzaldehyde
A solution containing 8.0 kg of 5-nitrovanillin and 8.7 kg of acetic acid in 35 kg of conc. hydrobromic acid was refluxed for 20 h.
0.6 kg of charcoal was added and the mixture was filtered.
32 kg of water was added with stirring and the solution was cooled to -10° C. and stirring was continued for 2 h more.
The crystalline product was filtered and washed with water.
Yield 5.66 kg (80percent), m.p. 135°-137° C.
Reference: [1] Patent: US4963590, 1990, A,
  • 3
  • [ 121-33-5 ]
  • [ 116313-85-0 ]
Reference: [1] Chemische Berichte, 1903, vol. 36, p. 2935
[2] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 24, p. 7318 - 7337
  • 4
  • [ 621-59-0 ]
  • [ 116313-85-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 18, p. 4367 - 4371
  • 5
  • [ 80547-69-9 ]
  • [ 116313-85-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 18, p. 4367 - 4371
  • 6
  • [ 116313-85-0 ]
  • [ 84211-30-3 ]
Reference: [1] Patent: US2014/163045, 2014, A1, . Location in patent: Paragraph 0083-0084
  • 7
  • [ 26391-06-0 ]
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With piperidine In 1,2-dimethoxyethane; n-heptane for 15 - 25 h; Heating / reflux
Stage #2: at 25 - 35℃; for 24 h;
Example- 1:Preparation of (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide (Entacapone).3,4-Dihydroxy-5-nitrobenzaldehyde (50 g), N,N-diethyl cyanoacetamide (76.5 g), piperidine (19.2 g), are charged to a reaction vessel containing a mixture of dimethoxy ethane (200 ml) and heptane (200 ml). The reaction mixture is refluxed for 15-25 hours till the starting material is <n="7"/>disappeared (monitored by HPLC). The solvent was removed by distillation under high vacuum at 70-80°C. Then cooled to 25-35°C. To the crude mass in the flask was added methylene chloride (1.0 lit) at 25°C-35°C. The mixture was stirred for 24 hours at that temperature. It is then filtered and dried and charged to reaction flask containing methanol. The mixture is charcolised, filtered and concentrated to give title compound in 75percent yield (HPLC 99.78percent, Z- isomer content <0.1percent).
75.5% With piperidine In isopropyl alcohol for 12 - 15 h; Heating / reflux Example 1
Crystallographically pure (E)-N,N-Diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide Form C
3,4-Dihydroxy-5-nitrobenzaldehyde (10.0 gm, 54.6 mmol), N,N-diethyl-cyanoacetamide (15.5 gm, 11.06 mmol) and piperidine (15.0 gm, 170.3 mmol) is charged to isopropanol (200 ml).
The reaction mixture is heated at reflux for 12 to 15 hours until the starting material is disappeared.
After the reaction is complete, the reaction mixture is cooled to room temperature and acetic acid glacial (15 ml) is added.
The reaction mixture is concentrated, followed by dilution with ethyl alcohol (50 ml).
The mixture is stirred overnight and filtered.
The isolated product is dried under vacuum to provide crystallographically pure Form C of crystalline (E)-N, N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide with melting point of 156-160° C.
The title product is obtained as a crystalline solid in 75.5percent yield. HPLC Purity=99.45percent (Z-isomer 0.24percent).
Mass Spectra=m+1 306.1 (100percent).
59.63%
Stage #1: With piperidine; acetic acid In ethanol for 6 h; Heating / reflux
Stage #2: at 65℃; for 0.5 h;
Example 1; A mixture of 3,4-dihydroxy-5-nitro benzaldehyde (50Og), N,N-diethyl cyano acetamide(575ml), acetic acid (375ml) and piperidine (500ml) in ethanol (4.51) were refluxed for 6 hrs. Ethanol was distilled off under vacuum and 1.5 1 of formic acid was added to the residue at65° C and stirred for 30 mins at 65° C. The reaction mixture was cooled to R T and charged with methylene dichloride. The organic layer was separated and washed twice with 2 x 3.5 1 water. Methylene dichloride was distilled off under vacuum from the organic layer and the residue was treated with ethyl acetate 1.25 1. The yellow solid was filtered out from the solvent, washed with 1.25 1 ethyl acetate and dried in an electric oven at 60-70° C to obtain crude N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitro phenyl) acrylamide.Yield of crude entacapone 495g (59.63 percent), Purity 99.2++Z- isomer 0.5percent
13% With 1-methyl-piperazine In methanol at 20℃; for 20 h; General procedure: A solution of arylaldehyde (1 equiv), 2-cyanoacetamide or derivative (1.0-1.5 equiv) and N-methylpiperazine (0.05-1.05 equiv) in methanol (2-10 ml) was stirred at room temperature overnight. After addition of an equivalent volume of water/methanol (1:1) or 1 N HCl/methanol (1:1) for acidic products, the precipitate was collected by filtration and washed with water/methanol (1:1). If precipitation did not occur, the mixture was evaporated and the residue was purified by flash chromatography.
99.80 % de
Stage #1: With piperidine In cyclohexane; toluene at 20 - 94℃;
Stage #2: With acetic acid In cyclohexane; toluene at 25 - 30℃;
Example 3; Preparation of Entacapone; 3,4-dihydroxy 5-nitrobenzaldehyde (17 gm) and diethylcyanoacetamide (16.9 gm) was charged in a solution of toluene (85 ml) and cyclohexane (85 ml ml) at rt followed by addition of piperidine (0.78 gm). The reaction temperature was raised to reflux (88-94° C.) and removed water azeotrophically from the reaction. After completion of reaction glacial acetic acid (34 ml) was added to reaction mixture followed by cooling at 25° C. to 30° C. The reaction mixture was stirred and filtered. The residue was washed with toluene and water. The residue was dried under vacuum at 50-55° C. to get Entacapone (22.7 gm).HPLC Purity: E-isomer 99.42percent and Z isomer content 0.10percent.
2.1 g
Stage #1: at 108 - 112℃; Dean-Stark
Stage #2: at 90 - 95℃; for 1 h;
A round bottomed flask equipped with a stirrer, thermowell, and a dean-Stark condenser was charged with 1.83 g of 3,4-dihydroxy-5-nitrobenzaldehyde, 1.54 g of N,N-diethyl-2-cyano acetamide, 150 mg of IRA 120 resin, and 15 mL of toluene. The mixture was refiuxed at 108 - 112 °C and the formed water was removed azeotropically until the starting material was consumed (approximately 12-16 hours). The resin was removed by filtration and the reaction mass was concentrated by distilling the solvent completely under vacuum. A mixture of geometric isomers was formed with the ratio of E/Z isomers being approximately 70:30. The concentrated mass was treated with a solution of 1percent HBr in acetic acid and maintained under stirring at 90-95 °C for 1 hour. The reaction mixture was cooled to room temperature and stirred for 20-24 hours. The reaction mixture was filtered and the precipitate recrystallized from alcohol to afford 2.1 g of Pure (E)-entacapone. The melting point of the resulting compound was 163.3 - 164.9 °C.

Reference: [1] Patent: WO2007/77572, 2007, A1, . Location in patent: Page/Page column 5-6
[2] Patent: US2008/4343, 2008, A1, . Location in patent: Page/Page column 5
[3] Patent: WO2005/63695, 2005, A1, . Location in patent: Page/Page column 11
[4] Patent: WO2007/54950, 2007, A1, . Location in patent: Example 1
[5] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 24, p. 7318 - 7337
[6] Patent: WO2005/70881, 2005, A1, . Location in patent: Page/Page column 7
[7] Patent: WO2007/77572, 2007, A1, . Location in patent: Page/Page column 6
[8] Patent: WO2008/23380, 2008, A1, . Location in patent: Page/Page column 7-8
[9] Patent: WO2008/23380, 2008, A1, . Location in patent: Page/Page column 8
[10] Patent: WO2008/53304, 2008, A2, . Location in patent: Page/Page column 5
[11] Patent: US2010/234632, 2010, A1, . Location in patent: Page/Page column 4
[12] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
[13] Patent: WO2014/164667, 2014, A1, . Location in patent: Page/Page column 29-30
  • 8
  • [ 26391-06-0 ]
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
  • [ 145195-63-7 ]
YieldReaction ConditionsOperation in experiment
75.5%
Stage #1: With piperidine In isopropyl alcohol for 12 - 15 h; Heating / reflux
Stage #2: With acetic acid In isopropyl alcohol at 20℃;
EXAMPLE 1;
Crystallographically pure (E)-N, N-Diethyl-2-cyano-3-(3, 4dihydroxy-5-nitrophenyl)- acrylamide Form C; 3,4-Dihydroxy-5-nitrobenzaldehyde (10.0 gm), N, N-Diethylcyanoacetamide (15.5 gm) and piperidine (15.0 gm) is charged to isopropanol (200 ml). The reaction mixture is refluxed for 12 to 15 hours till the starting material is disappeared. The solution is slowly cooled to room temperature and acetic acid glacial (15 ml) is added to it thereafter reaction mixture is concentrated followed by dilution with ethyl alcohol (50 ml). The mixture is stirred overnight and filtered. Isolated product thus obtained is dried under vacuum to afford crystallographically pure Form C of crystalline (E)-N, N-Diethyl-2-cyano-3- (3, 4-dihydroxy- 5-nitrophenyl) acrylamide with melting point between 156-160 °C. The title product is obtained as crystalline solid in 75.5 percent yield. HPLC Purity = 99.45percent (Z-isomer 0.24percent). Mass Spectra = m+1 306.1 (100percent).
41.99 % de
Stage #1: at 75 - 80℃;
Stage #2: With ammonium acetate In ethanol for 24 h;
1: Preparation of racemic 2-cvano-3-(3,4-dihvdroxy-5-nitrophenyl)-N,N-diethylprop-2~ en amide3,4-dihydroxy-5-nitro-benzaldehyde (5Og) and N,N-diethyl-2-cyano acetamide (99.4g) were taken together in dry ethanol (100OmL) and refluxed at 75-8O0C for 15-20min. followed by the addition of ammonium acetate (27g) lot-wise over a period of 24hrs at every 2 hours of interval. After completion of reaction the content was cooled to room temperature and the ethanol was distilled off under vacuum. The residue was taken in dichloromethane (100OmL) and stirred for 15min at 25-300C followed by the addition of purified water (100OmL) and stirred at 25-3O0C for 1 hr. The layer if not cleared was filtered through hyflobed and washed with methylene chloride. The organic layer was separated and the aqueous layer was washed with dichloromethane twice. The organic layer were combined and treated with dilute hydrochloric acid 30OmL (1:1 ratio of HCl and water). The organic layer was separated and treated with purified water to remove any undissolved impurities, the water treatment was repeated two to three times and further the organic layer was treated with activated carbon at 25-30 ° C and filtered. The filtrate distilled off under vacuum at 600C and the residue was taken in ethyl alcohol at 25-3O0C, stirred for 15- 20min. and distilled off under vacuum at 350C. To the residue was added purified water and the <n="9"/>stirred for 2 hrs at 25-300C3 filtered and washed with water and dried to obtain racemic 2-cyano- 3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide.(Dry Weight : 6Og (72.20percent), HPLC purity : 98.32percent, E isomer (69.80percent) and Z isomer (28.52percent)
40 % de With IRA 120 resin In toluene at 108 - 112℃; Dean-Stark A round bottomed flask equipped with a stirrer, thermowell, and a dean-Stark condenser was charged with 1.83 g of 3,4-dihydroxy-5-nitrobenzaldehyde, 1.54 g of N,N-diethyl-2-cyano acetamide, 150 mg of IRA 120 resin, and 15 mL of toluene. The mixture was refiuxed at 108 - 112 °C and the formed water was removed azeotropically until the starting material was consumed (approximately 12-16 hours). The resin was removed by filtration and the reaction mass was concentrated by distilling the solvent completely under vacuum. A mixture of geometric isomers was formed with the ratio of E/Z isomers being approximately 70:30. The concentrated mass was treated with a solution of 1percent HBr in acetic acid and maintained under stirring at 90-95 °C for 1 hour. The reaction mixture was cooled to room temperature and stirred for 20-24 hours. The reaction mixture was filtered and the precipitate recrystallized from alcohol to afford 2.1 g of Pure (E)-entacapone. The melting point of the resulting compound was 163.3 - 164.9 °C.
Reference: [1] Patent: WO2005/66117, 2005, A1, . Location in patent: Page/Page column 11
[2] Patent: WO2007/90923, 2007, A1, . Location in patent: Page/Page column 9-11
[3] Patent: WO2007/90923, 2007, A1, . Location in patent: Page/Page column 11-12
[4] Patent: WO2008/7093, 2008, A1, . Location in patent: Page/Page column 9
[5] Patent: WO2009/84031, 2009, A2, . Location in patent: Page/Page column 7-8
[6] Patent: WO2014/164667, 2014, A1, . Location in patent: Page/Page column 29-30
  • 9
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
Reference: [1] Patent: US4963590, 1990, A,
  • 10
  • [ 116313-85-0 ]
  • [ 130929-57-6 ]
Reference: [1] Synthetic Communications, 2012, vol. 42, # 9, p. 1359 - 1366
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 116313-85-0 ]

Entacapone Related Intermediates

Chemical Structure| 618-42-8

[ 618-42-8 ]

1-(Piperidin-1-yl)ethanone

Related Functional Groups of
[ 116313-85-0 ]

Aryls

Chemical Structure| 3011-34-5

[ 3011-34-5 ]

4-Hydroxy-3-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 704-13-2

[ 704-13-2 ]

3-Hydroxy-4-nitrobenzaldehyde

Similarity: 0.92

Chemical Structure| 6322-56-1

[ 6322-56-1 ]

4'-Hydroxy-3'-nitroacetophenone

Similarity: 0.88

Chemical Structure| 53967-72-9

[ 53967-72-9 ]

1-(3-Hydroxy-2-nitrophenyl)ethanone

Similarity: 0.86

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.85

Aldehydes

Chemical Structure| 3011-34-5

[ 3011-34-5 ]

4-Hydroxy-3-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 704-13-2

[ 704-13-2 ]

3-Hydroxy-4-nitrobenzaldehyde

Similarity: 0.92

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.85

Chemical Structure| 354512-22-4

[ 354512-22-4 ]

3-Methoxy-5-nitrobenzaldehyde

Similarity: 0.84

Chemical Structure| 2460-58-4

[ 2460-58-4 ]

2-Hydroxy-4-nitrobenzaldehyde

Similarity: 0.84

Nitroes

Chemical Structure| 3011-34-5

[ 3011-34-5 ]

4-Hydroxy-3-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 704-13-2

[ 704-13-2 ]

3-Hydroxy-4-nitrobenzaldehyde

Similarity: 0.92

Chemical Structure| 6322-56-1

[ 6322-56-1 ]

4'-Hydroxy-3'-nitroacetophenone

Similarity: 0.88

Chemical Structure| 53967-72-9

[ 53967-72-9 ]

1-(3-Hydroxy-2-nitrophenyl)ethanone

Similarity: 0.86

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.85